I am not critical of you being a Berman cheerleade
Post# of 11802
(Total Views: 347)
Posted On: 04/08/2019 10:22:45 AM
Re: thevibeguy #6921
I am not critical of you being a Berman cheerleader, but look at your posts from years ago and your opinion (which everyone is entitled to) is similar to other cheerleaders here. Notwithstanding your apparent infatuation with the CEO, the reality is he has always come up short on real results.
Just back from a wedding in Alaska and really expected more from the annual report. There is not anything new in there and as much as the 125 pages tends to be boasted about the majority is copy and past.
I did not see any diabetic strips at Pet Smart this weekend, but maybe they have not been distributed to the west coast yet. Reality is that Pet Smart will not produce significant sales. It would make more sense to get professionals to use the product.
Also disappointed to see that there has not been a follow-up on the Paragon press release. But even if they were to white label to large retailers I doubt it would make a major improvement in sales. The Company needs doctors to advocate for this new and improved version that is upcoming. The only way to achieve that is with a serious sales force which the company is incapable of funding. Or they need to partner with a large trusted pharma with a sales force. To be frank, a doctor is not going to trust this company no matter how much you praise the CEO. The average doctor has more money under their pillow than this company has in cash.
As far as this Platinum being duped into buying Lifescan and they need this new product through licensing I have my doubts. The other company cheerleader writes a licensing deal is imminent with Platinum in one post and then states Platinum wants nothing to do with them in another post. Hedge funds are generally not stupid, and Platinum might eventually just sell off the parts to make their investment in Lifescan see black ink.
This is your post that makes sense to me, although right now the court case seems to be a loser.
https://investorshangout.com/post/view?id=4983862
Time is against the Company because new forms of glucose monitoring are being developed. I am not an expert on diabetes, so I won't predict how long before better alternatives are mainstream than the model used here. But there is a phrase in investing, the trend is your friend.
The trend from a shareholder perspective here is a low price per share, high dilution and a constant $200,000 a month cash burn.
The trend from a business model is towards alternative types of medical devices.
A miracle court victory that results in a significant win is about the only big value driver.
Just back from a wedding in Alaska and really expected more from the annual report. There is not anything new in there and as much as the 125 pages tends to be boasted about the majority is copy and past.
I did not see any diabetic strips at Pet Smart this weekend, but maybe they have not been distributed to the west coast yet. Reality is that Pet Smart will not produce significant sales. It would make more sense to get professionals to use the product.
Also disappointed to see that there has not been a follow-up on the Paragon press release. But even if they were to white label to large retailers I doubt it would make a major improvement in sales. The Company needs doctors to advocate for this new and improved version that is upcoming. The only way to achieve that is with a serious sales force which the company is incapable of funding. Or they need to partner with a large trusted pharma with a sales force. To be frank, a doctor is not going to trust this company no matter how much you praise the CEO. The average doctor has more money under their pillow than this company has in cash.
As far as this Platinum being duped into buying Lifescan and they need this new product through licensing I have my doubts. The other company cheerleader writes a licensing deal is imminent with Platinum in one post and then states Platinum wants nothing to do with them in another post. Hedge funds are generally not stupid, and Platinum might eventually just sell off the parts to make their investment in Lifescan see black ink.
This is your post that makes sense to me, although right now the court case seems to be a loser.
https://investorshangout.com/post/view?id=4983862
Time is against the Company because new forms of glucose monitoring are being developed. I am not an expert on diabetes, so I won't predict how long before better alternatives are mainstream than the model used here. But there is a phrase in investing, the trend is your friend.
The trend from a shareholder perspective here is a low price per share, high dilution and a constant $200,000 a month cash burn.
The trend from a business model is towards alternative types of medical devices.
A miracle court victory that results in a significant win is about the only big value driver.
(0)
(0)Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼